{"event":"cholesterol-and-fasting-tracker","title":"Cholesterol and fasting research tracker 2026","state":"developing","updated":"2026-10-11T00:00:00.000Z","entries":[{"id":"1b66ubs","at":"2026-10-08T00:00:00.000Z","title":"CTX310 severe-hypertriglyceridemia data set for AHA late-breaker on 9 November","status":"confirmed","cites":[{"id":"gene-editing-ctx310-aha-2026","n":16,"url":"https://crisprtx.com/about-us/press-releases-and-presentations/crispr-therapeutics-to-present-late-breaking-data-at-the-american-heart-association-aha-scientific-sessions-2026","publisher":"CRISPR Therapeutics","short":"CRISPR Therapeutics"}]},{"id":"esk0wl","at":"2026-09-29T00:00:00.000Z","title":"Obicetrapib enters a Phase 2b Alzheimer's prevention trial","status":"confirmed","cites":[{"id":"health-metabolic-obicetrapib-alzheimers","n":29,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526406063/nams-20260929.htm","publisher":"NewAmsterdam Pharma (SEC filing)","short":"NewAmsterdam Pharma"}]},{"id":"37sdlu","at":"2026-09-21T00:00:00.000Z","title":"European Commission approves obicetrapib as Ubeslo and Evlarco","status":"confirmed","cites":[{"id":"health-metabolic-obicetrapib-ec-approval","n":3,"url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312526396716/nams-20260921.htm","publisher":"NewAmsterdam Pharma (SEC filing)","short":"NewAmsterdam Pharma"}]},{"id":"zete6n","at":"2026-09-04T00:00:00.000Z","title":"Pelacarsen misses primary endpoint in Lp(a)HORIZON outcome trial","status":"confirmed","cites":[{"id":"health-metabolic-lpa-horizon-result","n":4,"url":"https://www.sec.gov/Archives/edgar/data/0001114448/000117184326005896/f6k_090426.htm","publisher":"Novartis (SEC filing)","short":"Novartis"}]},{"id":"1ptqaq6","at":"2026-08-28T00:00:00.000Z","title":"One-year data for gene-editing therapy CTX310 show sustained LDL and triglyceride cuts","status":"confirmed","cites":[{"id":"gene-editing-ctx310-durability-2026","n":15,"url":"https://crisprtx.com/about-us/press-releases-and-presentations/crispr-therapeutics-presents-phase-1a-data-for-ctx310-demonstrating-deep-and-durable-angptl3-editing-triglyceride-and-ldl-lowering-at-esc-congress-2026","publisher":"CRISPR Therapeutics","short":"CRISPR Therapeutics"}]},{"id":"7rckuh","at":"2026-07-24T00:00:00.000Z","title":"EMA committee recommends approval of obicetrapib in the EU","status":"confirmed","cites":[{"id":"health-metabolic-obicetrapib-chmp","n":28,"url":"https://www.sec.gov/Archives/edgar/data/0001936258/000119312526315163/nams-ex99_1.htm","publisher":"NewAmsterdam Pharma (SEC filing)","short":"NewAmsterdam Pharma"}]},{"id":"x8pyle","at":"2026-07-15T00:00:00.000Z","title":"FDA approves enlicitide (Lipfendra), the first oral PCSK9 inhibitor","status":"confirmed","body":"Merck announced the approval on 16 July; the FDA record shows a 15 July action date.","cites":[{"id":"health-metabolic-lipfendra-approval","n":2,"url":"https://finance.yahoo.com/healthcare/articles/merck-lipfendra-enlicitide-first-only-104500842.html","publisher":"Merck & Co. (press release via Business Wire)","short":"Merck & Co."},{"id":"health-metabolic-lipfendra-trial-results","n":27,"url":"https://finance.yahoo.com/healthcare/articles/merck-lipfendra-enlicitide-first-only-104500842.html","publisher":"Merck & Co. (press release via Business Wire)","short":"Merck & Co."}]},{"id":"xihna5","at":"2026-06-24T00:00:00.000Z","title":"FDA approves olezarsen (Tryngolza) to cut triglycerides and pancreatitis risk in severe hypertriglyceridemia","status":"confirmed","cites":[{"id":"health-metabolic-tryngolza-shtg","n":12,"url":"https://www.sec.gov/Archives/edgar/data/874015/000114036126026232/ef20076807_ex99-1.htm","publisher":"Ionis Pharmaceuticals (SEC filing)","short":"Ionis Pharmaceuticals"}]},{"id":"jt1xnh","at":"2026-05-07T00:00:00.000Z","title":"NewAmsterdam plans PREVAIL interim analysis for late 2026","status":"confirmed","cites":[{"id":"health-metabolic-prevail-plan","n":11,"url":"https://www.sec.gov/Archives/edgar/data/0001936258/000119312526210283/nams-ex99_1.htm","publisher":"NewAmsterdam Pharma (SEC filing)","short":"NewAmsterdam Pharma"}]},{"id":"y6i7p2","at":"2026-03-27T00:00:00.000Z","title":"Trial finds time-restricted eating matches calorie restriction in women with PCOS","status":"confirmed","cites":[{"id":"health-metabolic-pcos-tre-2026","n":17,"url":"https://pubmed.ncbi.nlm.nih.gov/41896647/","publisher":"Nature Medicine","short":"Nature Medicine"}]},{"id":"w8yc24","at":"2026-03-13T00:00:00.000Z","title":"New ACC/AHA dyslipidemia guideline restores LDL goals and recommends Lp(a) testing for all adults","status":"confirmed","cites":[{"id":"health-metabolic-guideline-2026-published","n":1,"url":"https://www.acc.org/latest-in-cardiology/journal-scans/2026/03/13/15/20/acc-aha-release-new-clinical-guideline-for-managing-dyslipidemia","publisher":"American College of Cardiology","short":"American College…"},{"id":"health-metabolic-guideline-2026-ldl-goals","n":7,"url":"https://www.acc.org/latest-in-cardiology/journal-scans/2026/03/13/15/20/acc-aha-release-new-clinical-guideline-for-managing-dyslipidemia","publisher":"American College of Cardiology","short":"American College…"},{"id":"health-metabolic-guideline-2026-lpa","n":8,"url":"https://www.acc.org/latest-in-cardiology/journal-scans/2026/03/13/15/20/acc-aha-release-new-clinical-guideline-for-managing-dyslipidemia","publisher":"American College of Cardiology","short":"American College…"}]},{"id":"tauw8o","at":"2026-02-16T00:00:00.000Z","title":"Cochrane review finds intermittent fasting no better than regular dietary advice for weight loss","status":"confirmed","cites":[{"id":"health-metabolic-cochrane-2026","n":5,"url":"https://pubmed.ncbi.nlm.nih.gov/41692034/","publisher":"Cochrane Database of Systematic Reviews","short":"Cochrane Database…"},{"id":"health-metabolic-cochrane-2026-limits","n":26,"url":"https://pubmed.ncbi.nlm.nih.gov/41692034/","publisher":"Cochrane Database of Systematic Reviews","short":"Cochrane Database…"}]},{"id":"2zcmg6","at":"2026-02-05T00:00:00.000Z","title":"CORALreef Lipids results for oral enlicitide published in NEJM","status":"confirmed","cites":[{"id":"health-metabolic-coralreef-lipids","n":25,"url":"https://pubmed.ncbi.nlm.nih.gov/41879224/","publisher":"The New England Journal of Medicine","short":"The New England Journal…"}]},{"id":"gg6qgt","at":"2025-11-08T00:00:00.000Z","title":"VESALIUS-CV shows evolocumab prevents first heart attacks and strokes","status":"confirmed","cites":[{"id":"health-metabolic-vesalius","n":19,"url":"https://pubmed.ncbi.nlm.nih.gov/41211925/","publisher":"The New England Journal of Medicine","short":"The New England Journal…"}]},{"id":"h0jy7f","at":"2025-08-22T00:00:00.000Z","title":"Peer-reviewed 8-hour eating study published with hazard ratio of 2.35 and confounding caveat","status":"confirmed","cites":[{"id":"health-metabolic-chen-2025-paper","n":18,"url":"https://pubmed.ncbi.nlm.nih.gov/40849219/","publisher":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","short":"Diabetes & Metabolic…"}]},{"id":"l7haph","at":"2025-07-03T00:00:00.000Z","title":"BROADWAY trial of obicetrapib published, showing about a one-third LDL cut","status":"confirmed","cites":[{"id":"health-metabolic-broadway","n":24,"url":"https://pubmed.ncbi.nlm.nih.gov/40337982/","publisher":"The New England Journal of Medicine","short":"The New England Journal…"}]},{"id":"8il2jh","at":"2025-06-18T00:00:00.000Z","title":"BMJ network meta-analysis finds fasting diets broadly similar to calorie restriction","status":"confirmed","cites":[{"id":"health-metabolic-bmj-2025-nma","n":23,"url":"https://pubmed.ncbi.nlm.nih.gov/40533200/","publisher":"The BMJ","short":"The BMJ"}]},{"id":"4oqq49","at":"2024-03-18T00:00:00.000Z","title":"Conference abstract links eating windows under 8 hours to higher cardiovascular death","status":"confirmed","body":"Observational NHANES analysis of about 20,000 adults; the AHA called it preliminary.","cites":[{"id":"health-metabolic-aha-2024-tre-abstract","n":21,"url":"https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death","publisher":"American Heart Association Newsroom","short":"American Heart Association…"},{"id":"health-metabolic-aha-2024-tre-limits","n":22,"url":"https://newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death","publisher":"American Heart Association Newsroom","short":"American Heart Association…"}]},{"id":"1dvy5pa","at":"2021-12-22T00:00:00.000Z","title":"FDA approves inclisiran (Leqvio), a twice-yearly PCSK9-blocking injection","status":"confirmed","cites":[{"id":"health-metabolic-leqvio-approval","n":6,"url":"https://api.fda.gov/drug/drugsfda.json?search=products.brand_name:%22LEQVIO%22","publisher":"U.S. Food and Drug Administration","short":"U.S. Food and Drug…"},{"id":"health-metabolic-orion-inclisiran","n":20,"url":"https://pubmed.ncbi.nlm.nih.gov/32187462/","publisher":"The New England Journal of Medicine","short":"The New England Journal…"}]}]}